Axsome Therapeutics, Inc. ( AXSM) - Stock Earnings
AXSM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
AXSM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -28.6 million USD | 196.0 million USD |
| 2026Q1 | -64.5 million USD | 191.2 million USD |
| 2026Q2 | -51.3 million USD | 218.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AXSM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -239.2 million USD | 270.6 million USD |
| 2024 | -287.2 million USD | 385.7 million USD |
| 2025 | -183.2 million USD | 638.5 million USD |
| 2026 Est. | — | — |
AXSM
Price: $156.32
52 week price:
Earnings Per Share: -3.76 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.9 million
Ebitda: -6.3 millionMarket Capitalization: 9.2 billion